VARMA POINTS FOR PRIMARY DYSMENORRHEA

THERAPEUTIC EFFICTIVENESS OF VARMAM THERAPY IN THE MANAGEMENT OF SOOTHAGA VAYU(PRIMARY DYSMENORRHOEA) Ã¢â?¬â?? AN OPEN CLINICAL TRIAL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/044657

Enrollment

Registered

2022-08-04

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: VARMAM Undhi varmam Moothira varmam Poyikai varmam Vairuthi varmam Ani varmam Nadumuthukuvayu varmam Peru viral manjal varmam Ullangalvellai varmam Utchipathippu : Duration of t

Eligibility

Inclusion criteria

Inclusion criteria: Age : 15 Ã¢â?¬â?? 40 yrs. Pain in the lower abdomen before and after menstruation and at the time of during menstruation with or without radiating back and medial aspect of thighs. Patient who are willing to involve in the study by signing the consent and fulfilling the condition of Performa.

Exclusion criteria

Exclusion criteria: Ã¢â?¬Â¢ Endometritis Ã¢â?¬Â¢ Congenital anatomical abnormalities Ã¢â?¬Â¢ Pelvic inflammatory disease Ã¢â?¬Â¢ Adenomyosis Ã¢â?¬Â¢ Uterine leiomyoma Ã¢â?¬Â¢ Fibroid Ã¢â?¬Â¢ Carcinoma

Design outcomes

Primary

Measure	Time frame
Outcome of this study will be assessed by MDVS scale (Multi-Dimensional Verbal Scale )Timepoint: 90 days (12 sitting)	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Karthiga G

National Institute of Siddha

sami2011nis@gmail.com7358481734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026